U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 216340

KRAZATI (ADAGRASIB)
200MG
Marketing Status: Prescription
Active Ingredient: ADAGRASIB
Proprietary Name: KRAZATI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N216340
Product Number: 001
Approval Date: Dec 12, 2022
Applicant Holder Full Name: MIRATI THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top